nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—ABCB1—adrenal gland cancer	0.991	1	CbGaD
Fentanyl—Loperamide—POMC—adrenal gland cancer	0.00353	0.405	CrCbGaD
Fentanyl—Alfentanil—ABCB1—adrenal gland cancer	0.00119	0.137	CrCbGaD
Fentanyl—Astemizole—ABCB1—adrenal gland cancer	0.000929	0.107	CrCbGaD
Fentanyl—Phenylbutazone—PTGS2—adrenal gland cancer	0.000671	0.077	CrCbGaD
Fentanyl—Fexofenadine—ABCB1—adrenal gland cancer	0.000662	0.0759	CrCbGaD
Fentanyl—Propafenone—ABCB1—adrenal gland cancer	0.000533	0.0612	CrCbGaD
Fentanyl—Bepridil—ABCB1—adrenal gland cancer	0.000475	0.0545	CrCbGaD
Fentanyl—Loperamide—ABCB1—adrenal gland cancer	0.000421	0.0483	CrCbGaD
Fentanyl—Methadone—ABCB1—adrenal gland cancer	0.0003	0.0344	CrCbGaD
Fentanyl—OPRD1—Peptide GPCRs—GNRHR—adrenal gland cancer	4.26e-05	0.0613	CbGpPWpGaD
Fentanyl—OPRK1—Peptide GPCRs—GNRHR—adrenal gland cancer	3.73e-05	0.0538	CbGpPWpGaD
Fentanyl—OPRM1—Peptide GPCRs—GNRHR—adrenal gland cancer	3.16e-05	0.0455	CbGpPWpGaD
Fentanyl—OPRD1—Peptide GPCRs—TSHR—adrenal gland cancer	2.27e-05	0.0327	CbGpPWpGaD
Fentanyl—OPRK1—Peptide GPCRs—TSHR—adrenal gland cancer	1.99e-05	0.0287	CbGpPWpGaD
Fentanyl—OPRM1—Peptide GPCRs—TSHR—adrenal gland cancer	1.69e-05	0.0243	CbGpPWpGaD
Fentanyl—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	1.65e-05	0.0237	CbGpPWpGaD
Fentanyl—OPRM1—G-protein activation—POMC—adrenal gland cancer	1.48e-05	0.0213	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	1.34e-05	0.0193	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	1.18e-05	0.017	CbGpPWpGaD
Fentanyl—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	1.17e-05	0.0168	CbGpPWpGaD
Fentanyl—OPRM1—Opioid Signalling—PRKACA—adrenal gland cancer	1.12e-05	0.0162	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—GNRHR—adrenal gland cancer	1.02e-05	0.0147	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	9.96e-06	0.0143	CbGpPWpGaD
Fentanyl—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	9.02e-06	0.013	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—GNRHR—adrenal gland cancer	8.97e-06	0.0129	CbGpPWpGaD
Fentanyl—OPRM1—TCR Signaling Pathway—CDC42—adrenal gland cancer	8.77e-06	0.0126	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	8.05e-06	0.0116	CbGpPWpGaD
Fentanyl—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	7.89e-06	0.0114	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—GNRHR—adrenal gland cancer	7.58e-06	0.0109	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	7.17e-06	0.0103	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	7.06e-06	0.0102	CbGpPWpGaD
Fentanyl—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	6.71e-06	0.00967	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	6.29e-06	0.00906	CbGpPWpGaD
Fentanyl—OPRM1—Opioid Signalling—POMC—adrenal gland cancer	6.14e-06	0.00884	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—GNRH1—adrenal gland cancer	6.13e-06	0.00883	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	5.96e-06	0.00859	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—GNRHR—adrenal gland cancer	5.78e-06	0.00833	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—TSHR—adrenal gland cancer	5.46e-06	0.00787	CbGpPWpGaD
Fentanyl—CYP3A7—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	5.44e-06	0.00784	CbGpPWpGaD
Fentanyl—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	5.44e-06	0.00783	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—GNRH1—adrenal gland cancer	5.37e-06	0.00774	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	5.32e-06	0.00766	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	5.25e-06	0.00757	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—GNRHR—adrenal gland cancer	5.25e-06	0.00756	CbGpPWpGaD
Fentanyl—OPRD1—G alpha (i) signalling events—GNAS—adrenal gland cancer	5.25e-06	0.00756	CbGpPWpGaD
Fentanyl—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	5.18e-06	0.00746	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—GNRHR—adrenal gland cancer	5.07e-06	0.0073	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	4.89e-06	0.00704	CbGpPWpGaD
Fentanyl—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	4.85e-06	0.00699	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—TSHR—adrenal gland cancer	4.79e-06	0.0069	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—GNRHR—adrenal gland cancer	4.6e-06	0.00663	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—GNAS—adrenal gland cancer	4.6e-06	0.00663	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	4.54e-06	0.00654	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	4.28e-06	0.00617	CbGpPWpGaD
Fentanyl—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	4.23e-06	0.00609	CbGpPWpGaD
Fentanyl—OPRD1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	4.19e-06	0.00603	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—TSHR—adrenal gland cancer	4.05e-06	0.00583	CbGpPWpGaD
Fentanyl—CYP3A5—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	3.93e-06	0.00567	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	3.89e-06	0.0056	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—GNAS—adrenal gland cancer	3.89e-06	0.0056	CbGpPWpGaD
Fentanyl—OPRK1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	3.67e-06	0.00529	CbGpPWpGaD
Fentanyl—OPRD1—G alpha (i) signalling events—POMC—adrenal gland cancer	3.53e-06	0.00509	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—GNRH1—adrenal gland cancer	3.46e-06	0.00499	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—GNAS—adrenal gland cancer	3.18e-06	0.00458	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—GNRH1—adrenal gland cancer	3.14e-06	0.00453	CbGpPWpGaD
Fentanyl—OPRM1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	3.1e-06	0.00447	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GNRHR—adrenal gland cancer	3.1e-06	0.00447	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—POMC—adrenal gland cancer	3.1e-06	0.00446	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—TSHR—adrenal gland cancer	3.09e-06	0.00445	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—GNRH1—adrenal gland cancer	3.04e-06	0.00437	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	3.02e-06	0.00435	CbGpPWpGaD
Fentanyl—CYP3A7—Biological oxidations—POMC—adrenal gland cancer	2.89e-06	0.00416	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SH3KBP1—adrenal gland cancer	2.88e-06	0.00415	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	2.81e-06	0.00405	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—TSHR—adrenal gland cancer	2.8e-06	0.00404	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—GNAS—adrenal gland cancer	2.79e-06	0.00401	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—GNRH1—adrenal gland cancer	2.76e-06	0.00397	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GNRHR—adrenal gland cancer	2.72e-06	0.00392	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ZNRF3—adrenal gland cancer	2.71e-06	0.0039	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—TSHR—adrenal gland cancer	2.71e-06	0.0039	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—POMC—adrenal gland cancer	2.62e-06	0.00377	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—SDHB—adrenal gland cancer	2.58e-06	0.00372	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	2.57e-06	0.0037	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SH3KBP1—adrenal gland cancer	2.53e-06	0.00364	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	2.46e-06	0.00355	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—TSHR—adrenal gland cancer	2.46e-06	0.00354	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ZNRF3—adrenal gland cancer	2.38e-06	0.00342	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—GNAS—adrenal gland cancer	2.35e-06	0.00339	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	2.33e-06	0.00336	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GNRHR—adrenal gland cancer	2.3e-06	0.00331	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	2.29e-06	0.00329	CbGpPWpGaD
Fentanyl—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	2.26e-06	0.00325	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—POMC—adrenal gland cancer	2.14e-06	0.00308	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	2.14e-06	0.00308	CbGpPWpGaD
Fentanyl—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	2.09e-06	0.00301	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	2.08e-06	0.003	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—TSHR—adrenal gland cancer	2.08e-06	0.00299	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PRKACA—adrenal gland cancer	2.01e-06	0.0029	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	2.01e-06	0.00289	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CDC42—adrenal gland cancer	1.88e-06	0.00271	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—POMC—adrenal gland cancer	1.88e-06	0.0027	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—SDHB—adrenal gland cancer	1.87e-06	0.00269	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GNRH1—adrenal gland cancer	1.86e-06	0.00268	CbGpPWpGaD
Fentanyl—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	1.83e-06	0.00263	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—GNAS—adrenal gland cancer	1.8e-06	0.00259	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PRKACA—adrenal gland cancer	1.76e-06	0.00254	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CDC42—adrenal gland cancer	1.71e-06	0.00246	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SPRY2—adrenal gland cancer	1.7e-06	0.00245	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—SDHD—adrenal gland cancer	1.67e-06	0.0024	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—RRM1—adrenal gland cancer	1.67e-06	0.0024	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TSHR—adrenal gland cancer	1.66e-06	0.00238	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CDC42—adrenal gland cancer	1.65e-06	0.00237	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—GNAS—adrenal gland cancer	1.63e-06	0.00235	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GNRH1—adrenal gland cancer	1.63e-06	0.00235	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—POMC—adrenal gland cancer	1.59e-06	0.00228	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—GNAS—adrenal gland cancer	1.57e-06	0.00227	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	1.57e-06	0.00227	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MEN1—adrenal gland cancer	1.56e-06	0.00224	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CDC42—adrenal gland cancer	1.5e-06	0.00216	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	1.49e-06	0.00215	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SPRY2—adrenal gland cancer	1.49e-06	0.00215	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TSHR—adrenal gland cancer	1.45e-06	0.00209	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—GNAS—adrenal gland cancer	1.43e-06	0.00206	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SDHB—adrenal gland cancer	1.41e-06	0.00203	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	1.39e-06	0.00201	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GNRH1—adrenal gland cancer	1.38e-06	0.00198	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MEN1—adrenal gland cancer	1.37e-06	0.00197	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	1.33e-06	0.00192	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CDC42—adrenal gland cancer	1.26e-06	0.00182	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SPRY2—adrenal gland cancer	1.26e-06	0.00181	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—MED12—adrenal gland cancer	1.24e-06	0.00179	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TSHR—adrenal gland cancer	1.23e-06	0.00177	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—POMC—adrenal gland cancer	1.21e-06	0.00174	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—GNAS—adrenal gland cancer	1.21e-06	0.00174	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—SDHD—adrenal gland cancer	1.2e-06	0.00173	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—RRM1—adrenal gland cancer	1.2e-06	0.00173	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PRKACA—adrenal gland cancer	1.19e-06	0.00171	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	1.16e-06	0.00167	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MEN1—adrenal gland cancer	1.15e-06	0.00166	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—POMC—adrenal gland cancer	1.1e-06	0.00158	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—POMC—adrenal gland cancer	1.06e-06	0.00153	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.05e-06	0.00152	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PRKACA—adrenal gland cancer	1.04e-06	0.0015	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	1.03e-06	0.00149	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CDC42—adrenal gland cancer	1.01e-06	0.00145	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IGF2—adrenal gland cancer	9.72e-07	0.0014	CbGpPWpGaD
Fentanyl—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	9.71e-07	0.0014	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GNAS—adrenal gland cancer	9.63e-07	0.00139	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—POMC—adrenal gland cancer	9.63e-07	0.00139	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IGF1R—adrenal gland cancer	9.39e-07	0.00135	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—RRM1—adrenal gland cancer	9.08e-07	0.00131	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SDHD—adrenal gland cancer	9.08e-07	0.00131	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	9.06e-07	0.0013	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—MED12—adrenal gland cancer	8.98e-07	0.00129	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—POMC—adrenal gland cancer	8.96e-07	0.00129	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CDC42—adrenal gland cancer	8.84e-07	0.00127	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PRKACA—adrenal gland cancer	8.81e-07	0.00127	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SDHB—adrenal gland cancer	8.69e-07	0.00125	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	8.55e-07	0.00123	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF2—adrenal gland cancer	8.52e-07	0.00123	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GNAS—adrenal gland cancer	8.45e-07	0.00122	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF1R—adrenal gland cancer	8.24e-07	0.00119	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	8.2e-07	0.00118	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—POMC—adrenal gland cancer	8.14e-07	0.00117	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TERT—adrenal gland cancer	8.09e-07	0.00116	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CDC42—adrenal gland cancer	7.47e-07	0.00108	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GNAS—adrenal gland cancer	7.34e-07	0.00106	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	7.2e-07	0.00104	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF2—adrenal gland cancer	7.2e-07	0.00104	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GNAS—adrenal gland cancer	7.14e-07	0.00103	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TERT—adrenal gland cancer	7.09e-07	0.00102	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—BAD—adrenal gland cancer	7.03e-07	0.00101	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF1R—adrenal gland cancer	6.96e-07	0.001	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	6.88e-07	0.000991	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—MED12—adrenal gland cancer	6.77e-07	0.000976	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	6.55e-07	0.000943	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—POMC—adrenal gland cancer	6.49e-07	0.000934	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—BRAF—adrenal gland cancer	6.4e-07	0.000922	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—EGFR—adrenal gland cancer	6.21e-07	0.000894	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—BAD—adrenal gland cancer	6.17e-07	0.000888	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TERT—adrenal gland cancer	5.99e-07	0.000863	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—POMC—adrenal gland cancer	5.69e-07	0.000819	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—BRAF—adrenal gland cancer	5.62e-07	0.000809	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SDHD—adrenal gland cancer	5.6e-07	0.000806	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—RRM1—adrenal gland cancer	5.6e-07	0.000806	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—EGFR—adrenal gland cancer	5.44e-07	0.000784	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GNAS—adrenal gland cancer	5.31e-07	0.000764	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—BAD—adrenal gland cancer	5.21e-07	0.000751	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	5.21e-07	0.00075	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—POMC—adrenal gland cancer	4.94e-07	0.000712	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PRKACA—adrenal gland cancer	4.94e-07	0.000712	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—POMC—adrenal gland cancer	4.81e-07	0.000692	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—BRAF—adrenal gland cancer	4.75e-07	0.000684	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	4.63e-07	0.000667	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—EGFR—adrenal gland cancer	4.6e-07	0.000663	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MED12—adrenal gland cancer	4.17e-07	0.000601	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CTNNB1—adrenal gland cancer	4.06e-07	0.000585	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GNAS—adrenal gland cancer	4e-07	0.000577	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	3.94e-07	0.000568	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EGFR—adrenal gland cancer	3.67e-07	0.000528	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—POMC—adrenal gland cancer	3.57e-07	0.000515	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	3.43e-07	0.000494	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EGFR—adrenal gland cancer	3.22e-07	0.000463	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TP53—adrenal gland cancer	3.08e-07	0.000443	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	3.04e-07	0.000438	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	2.85e-07	0.000411	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EGFR—adrenal gland cancer	2.72e-07	0.000391	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TP53—adrenal gland cancer	2.7e-07	0.000389	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—POMC—adrenal gland cancer	2.7e-07	0.000388	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GNAS—adrenal gland cancer	2.47e-07	0.000355	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	2.42e-07	0.000349	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TP53—adrenal gland cancer	2.28e-07	0.000329	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS2—adrenal gland cancer	2.15e-07	0.00031	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—POMC—adrenal gland cancer	1.66e-07	0.000239	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	1.33e-07	0.000191	CbGpPWpGaD
